Dualitas Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-11-18.
Dualitas Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on November 18, 2025. The filing reports $32.60M sold. Its industry group is Biotechnology. It names Richard Murray (Executive Officer, Director), Forbes Huang (Executive Officer), Nikola Trbovic (Director) (SEC Form D, November 18, 2025).
Is this your company?
Sell to companies like Dualitas Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-11-18 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Dualitas Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Dualitas Therapeutics, Inc., from the filings we hold.
Biotechnology raises by companies based in California, filed in November 2025, largest first.
Get an email when Dualitas Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Dualitas Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Dualitas Therapeutics, Inc. →Get the full cited report on Dualitas Therapeutics, Inc.
What the filing shows about Dualitas Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Dualitas Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Dualitas Therapeutics, Inc.'s address as 681 Gateway Boulevard, Suite 411, South San Francisco, CA 94080.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Dualitas Therapeutics, Inc. See pricing
Dualitas Therapeutics, Inc. is a registered filer with the SEC (CIK 2091994) and has filed since 2025-11-18. 1 filing is on record, the latest on 2025-11-18.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Dualitas Therapeutics, Inc.'s Form D of 2025-11-18 names Richard Murray, Forbes Huang, Nikola Trbovic and 6 more as its officers, directors or promoters.
Its new offerings report $32.60M sold across 1 offering, as its own filings state.
Trailing twelve months. 764 filings in Biotechnology, totalled by week. The dot is this raise, $32.60M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Richard Murray is named as Executive Officer and Director on the Form D that Dualitas Therapeutics, Inc. filed with the SEC on 18 November 2025, one of 9 people that filing names.
Forbes Huang is named as Executive Officer on the Form D that Dualitas Therapeutics, Inc. filed with the SEC on 18 November 2025, one of 9 people that filing names.
Nikola Trbovic is named as Director on the Form D that Dualitas Therapeutics, Inc. filed with the SEC on 18 November 2025, one of 9 people that filing names.
Neil Weir is named as Director on the Form D that Dualitas Therapeutics, Inc. filed with the SEC on 18 November 2025, one of 9 people that filing names.
Alicia Levey is named as Director on the Form D that Dualitas Therapeutics, Inc. filed with the SEC on 18 November 2025, one of 9 people that filing names.
Thomas Hudson is named as Director on the Form D that Dualitas Therapeutics, Inc. filed with the SEC on 18 November 2025, one of 9 people that filing names.
Mark McDade is named as Director on the Form D that Dualitas Therapeutics, Inc. filed with the SEC on 18 November 2025, one of 9 people that filing names.
Greg Lazar is named as Executive Officer on the Form D that Dualitas Therapeutics, Inc. filed with the SEC on 18 November 2025, one of 9 people that filing names.
Michael Ross is named as Director on the Form D that Dualitas Therapeutics, Inc. filed with the SEC on 18 November 2025, one of 9 people that filing names.
9 people named on the filing — 3 holding an executive role and 6 as directors only.
Named as of the 2025-11-18 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Dualitas Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Dualitas Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Dualitas Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Dualitas Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Dualitas Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Dualitas Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/dualitas-therapeutics-inc-form-d-25000001